Fady Hannah-Shmouni, MD FRCPC
About Fady Hannah-Shmouni, MD FRCPC
Fady Hannah-Shmouni, MD FRCPC, is a physician-investor and serial entrepreneur. He is a board-certified endocrinologist and clinical biochemical geneticist. He trained in internal medicine at Yale University School of Medicine (2012 to 2015) and did a fellowship at the National Institutes of Health (2015 to 2017). He then did a clinical biochemical genetics fellowship at the University of Toronto (2017 to 2018). His MD is from the University of Jordan School of Medicine (2003 to 2009).
At the NICHD/NIH he was Principal Investigator and Associate Investigator from 2015 to 2021, working on cortisol and growth hormone dysregulation. From 2019 to 2021 he was Associate Program Director and Director of Graduate Medical Education for the NIH Endocrinology Fellowship Program. He was also Founding Editor-in-Chief of Endocrine and Metabolic Science (Elsevier, 2019 to 2023). His research has contributed to more than 100 peer-reviewed publications. He is an Assistant Clinical Professor at the University of British Columbia.
On the business side, he co-founded FHS Capital, an early-stage venture capital and venture builder firm. Crunchbase lists him as Strategic Advisor there, while his personal site and X profile describe him as Managing Partner. He is Founder and CEO of Hormonaly.ai. A LinkedIn post from an earlier period lists him as Founder and CEO of Healthspan Digital Inc. In 2024 he joined the faculty of the Geneva College of Longevity Science, and in 2025 he became Director of its AI Academy. Crunchbase counts four companies founded.
Crunchbase lists 14 investments in 14 portfolio companies, 3 of them as lead investor, and no exits. Investment dates are not shown in the public profile, so this page does not attach years to individual deals.
Much of his deal activity runs through FHS Capital, which describes itself as having funded more than 40 companies across healthcare, AI, FinTech, CleanTech and SaaS in North America and the MENA region. FHS Capital's LinkedIn page has congratulated portfolio company Homecare Hub on a seed round that it described as alongside other named investors. That is a firm-level announcement and not a confirmed personal angel check.
His Crunchbase bio names AI Nexus, Neurable and DrVibe.ai among his portfolio and advisory work. His X profile also links DrVibe.ai and describes him as a vibe coder. Eli Health, Flyby, Science & Humans, Supernatural, Acorn Biolabs and NU appear in the same list, and these span health, longevity and consumer technology.
As an operator he runs Hormonaly.ai, which he describes as the Evidence OS for peptide, hormone and longevity medicine. It is an AI clinical platform that gives clinicians GRADE-rated evidence synthesis. A May 2026 press release said the platform was in production with more than 400 practitioners and 10 enterprise customers. It also said the platform supports English and Arabic and offers U.S. and GCC data residency. The company's public GitHub page says Hormonaly is a portfolio company of KBW Ventures.
The public record points to early-stage investing. FHS Capital calls itself an early-stage venture capital and venture builder firm. Sectors named in his bio are healthcare, AI, FinTech, CleanTech and SaaS. His own writing centers on precision diagnostics, longevity medicine and AI-driven healthcare. His geographic reach is North America and the MENA region, and he is based in Dubai.
He has not published a personal check size or ownership targets that we could find. He has also not published a formal list of what he screens for. Founders with a clinical, longevity or health AI product will find the closest match to his background and operating experience.
- Hormonaly.ai: AI clinical platform for peptide, hormone and longevity medicine, founded and led by him as CEO.
- DrVibe.ai: named in his Crunchbase portfolio and advisory list and linked from his X profile.
- Eli Health: named in his Crunchbase portfolio and advisory list.
- Flyby: named in his Crunchbase portfolio and advisory list.
- Science & Humans: named in his Crunchbase portfolio and advisory list.
- Supernatural: named in his Crunchbase portfolio and advisory list.
- Acorn Biolabs: named in his Crunchbase portfolio and advisory list.
- NU: named in his Crunchbase portfolio and advisory list.
- AI Nexus: named in his Crunchbase portfolio and advisory list.
- Neurable: named in his Crunchbase portfolio and advisory list.
- crunchbase.com/person/fady-hannah-shmouni-f393
- shmouni.com
- x.com/drshmouni
- linkedin.com/in/fady-hannah-shmouni
- linkedin.com/company/fhs-capital
- github.com/Hormonaly-ai/hormonaly-public
- businesswire.com/news/home/20260505592455/en/Hormonaly.ai-Opens-Clinic
- linkedin.com/posts/fady-hannah-shmouni_want-to-live-longer-and-healthi
Investing activity
Fady Hannah-Shmouni, MD FRCPC has made 14 investments according to Crunchbase across 14 portfolio companies, and has led 3 rounds and founded 4 companies.
Deals
Frequently asked questions about Fady Hannah-Shmouni, MD FRCPC
Does Fady Hannah-Shmouni invest in AI startups?
Yes. His Crunchbase bio lists AI Nexus, Neurable and DrVibe.ai in his portfolio and advisory work, and FHS Capital names AI as a sector. He also founded the AI platform Hormonaly.ai.
What stage does Fady Hannah-Shmouni invest at?
FHS Capital, which he co-founded, describes itself as early-stage. Crunchbase shows 14 investments, 3 as lead. No personal stage policy is published.
What is Fady Hannah-Shmouni's check size?
No personal check size is public, so we have not listed one. Founders should ask directly.
What sectors does Fady Hannah-Shmouni back?
His bio names healthcare, AI, FinTech, CleanTech and SaaS, in North America and the MENA region. His own work centers on longevity medicine, precision diagnostics and AI-driven healthcare.
Where is Fady Hannah-Shmouni based?
Crunchbase lists Dubai, United Arab Emirates. His X profile shows other locations, so confirm before planning a meeting.
How can founders contact Fady Hannah-Shmouni?
Founders can use his LinkedIn profile, his X account @DrShmouni, or his personal site at shmouni.com. FHS Capital is at fhscapital.io.
Is Fady Hannah-Shmouni, MD FRCPC an angel investor?
Yes. Fady Hannah-Shmouni, MD FRCPC invests personally as an angel. Crunchbase counts 14 investments.
Where is Fady Hannah-Shmouni, MD FRCPC based?
Fady Hannah-Shmouni, MD FRCPC is based in Dubai, Dubai, United Arab Emirates.
How can founders reach Fady Hannah-Shmouni, MD FRCPC?
Founders on Lounge can see Fady Hannah-Shmouni, MD FRCPC's contact details in AI Investor Contacts (paid plans), check for a warm introduction through members who worked with them under Warm Paths, and add Fady Hannah-Shmouni, MD FRCPC to their Investor Pipeline to track the conversation.